Spots Global Cancer Trial Database for stage iva prostate cancer ajcc v8

Every month we try and update this database with for stage iva prostate cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma	NCT04945642	Prostate Adenoc... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	High-Dose Rate ... Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer	NCT04754425	Castration-Resi... Castration-Resi... Metastatic Mali... Metastatic Pros... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Biopsy Biospecimen Col... Erdafitinib	18 Years -	M.D. Anderson Cancer Center
Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer	NCT03360721	Castration-Resi... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy	NCT04915508	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hormone Therapy Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer	NCT03649841	Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera...	18 Years -	University of Washington
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy	NCT04927559	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Survey Administ...	18 Years -	University of Southern California
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring	NCT05054296	Biochemically R... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Educational Int... Exercise Interv... FitBit Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression	NCT04927663	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Solid Tumor, Ad... Solid Tumor Metastatic Cast...	Computed Tomogr... Magnetic Resona... Positron Emissi... 11C-YJH08 Optional Tumor ...	18 Years -	University of California, San Francisco
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers	NCT04388852	Aggressive Vari... Castration-Resi... Metastatic Clea... Metastatic Mali... Metastatic Pros... Metastatic Urot... Stage IV Prosta... Stage IV Renal ... Stage IVA Prost... Stage IVB Prost...	Ipilimumab Valemetostat	18 Years -	M.D. Anderson Cancer Center
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion	NCT04976257	Prostate Adenoc... Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Angiogram Catheterization Gallium Ga-labe... Positron Emissi...	18 Years - 80 Years	University of California, San Francisco
Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones	NCT04616547	Castration-Resi... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Questionnaire A... Tin Sn 117m Pen...	18 Years -	National Cancer Institute (NCI)
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05037500	Castration-Resi... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine and ... Enzalutamide	18 Years -	Roswell Park Cancer Institute
Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate Cancer	NCT04279561	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Jonsson Comprehensive Cancer Center
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer	NCT03581500	Prostate Adenoc... PSA Level Great... Stage IIB Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hyperpolarized ... Magnetic Resona...	-	M.D. Anderson Cancer Center
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery	NCT03218826	Advanced Breast... Advanced Malign... Advanced Prosta... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Castration-Resi... Metastatic Brea... Metastatic Mali... Metastatic Pros... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Triple-Negative... Unresectable So...	Docetaxel Laboratory Biom... Pharmacological... PI3Kbeta Inhibi...	18 Years -	National Cancer Institute (NCI)
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study	NCT03707574	Advanced Malign... Advanced Melano... Advanced Renal ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Lung ... Stage III Ovari... Stage III Prost... Stage IIIA Colo... Stage IIIA Lung... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Colo... Stage IIIB Lung... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Lung... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Lung C... Stage IV Ovaria... Stage IV Prosta... Stage IVA Color... Stage IVA Lung ... Stage IVA Ovari... Stage IVA Prost... Stage IVB Color... Stage IVB Lung ... Stage IVB Ovari... Stage IVB Prost... Stage IVC Color...	Biospecimen Col...	18 Years -	National Cancer Institute (NCI)
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancer	NCT04947254	Prostate Carcin... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Abiraterone Ace... Antiandrogen Th... Apalutamide Biopsy Niraparib Prednisone Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	NCT05946213	Stage III Prost... Stage IVA Prost...	External Beam R... Stereotactic Bo...	18 Years -	NRG Oncology
Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer	NCT03649841	Castration-Sens... Metastatic Mali... Metastatic Pros... Prostate Adenoc... Prostate Small ... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Antiandrogen Th... Abiraterone Ace... Prednisone Radiation Thera...	18 Years -	University of Washington
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer	NCT05034562	Metastatic Pros... Recurrent Prost... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Magnetic Resona... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer	NCT04050215	Biochemically R... Metastatic Pros... Prostate Adenoc... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Positron Emissi... Questionnaire A...	18 Years -	Jonsson Comprehensive Cancer Center
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors	NCT03784677	Advanced Malign... Refractory Mali... Refractory Ovar... Refractory Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Ovari... Stage IVA Prost... Stage IVB Ovari... Stage IVB Prost...	TRPV6 Calcium C...	18 Years -	M.D. Anderson Cancer Center
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer	NCT05946213	Stage III Prost... Stage IVA Prost...	External Beam R... Stereotactic Bo...	18 Years -	NRG Oncology
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring	NCT05054296	Biochemically R... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Educational Int... Exercise Interv... FitBit Quality-of-Life... Questionnaire A...	18 Years -	M.D. Anderson Cancer Center
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy	NCT04927559	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Survey Administ...	18 Years -	University of Southern California
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies	NCT03217747	Advanced Malign... Castration-Resi... Malignant Solid... Metastatic Mali... Metastatic Pros... Prostate Carcin... Refractory Mali... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Avelumab Ivuxolimab Radiation Thera... Utomilumab	18 Years -	M.D. Anderson Cancer Center
68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy	NCT04928820	Biochemically R... Metastatic Mali... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68 G... Positron Emissi...	18 Years -	Jonsson Comprehensive Cancer Center
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)	NCT05241860	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Pharmacotherapy... Follow-Up Questionnaire A... Quality-of-Life...	18 Years -	Alliance for Clinical Trials in Oncology
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer	NCT03821792	Metastatic Pros... Prostate Adenoc... Prostate Carcin... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Apalutamide Prednisone	18 Years -	M.D. Anderson Cancer Center
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers	NCT05722288	Localized Prost... Locally Advance... Locally Advance... Malignant Solid... Recurrent Prost... Stage I Prostat... Stage IB Cervic... Stage IB2 Cervi... Stage II Prosta... Stage II Rectal... Stage IIA Cervi... Stage IIB Cervi... Stage III Prost... Stage III Recta... Stage IIIA Cerv... Stage IIIB Cerv... Stage IIIC Cerv... Stage IVA Prost...	Biospecimen Col... Informational I... Quality-of-Life... Questionnaire A... Short-Term Fast...	18 Years -	City of Hope Medical Center
Gallium-68 PSMA-11 PET in Participants With Prostate Cancer	NCT05034562	Metastatic Pros... Recurrent Prost... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Magnetic Resona... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer	NCT04716725	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	68Ga-PSMA-11 Positron Emissi...	18 Years -	University of California, San Francisco
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes	NCT04501913	Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Clinical Stage ... Hepatobiliary N... Malignant Diges... Malignant Femal... Malignant Genit... Malignant Neopl... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Postneoadjuvant... Stage 0 Colorec... Stage 0a Bladde... Stage 0is Bladd... Stage I Bladder... Stage I Cervica... Stage I Colorec... Stage I Ovarian... Stage I Prostat... Stage I Renal C... Stage I Uterine... Stage IA Cervic... Stage IA Ovaria... Stage IA Uterin... Stage IA1 Cervi... Stage IA2 Cervi... Stage IB Cervic... Stage IB Ovaria... Stage IB Uterin... Stage IB1 Cervi... Stage IB2 Cervi... Stage IC Ovaria... Stage II Bladde... Stage II Cervic... Stage II Colore... Stage II Ovaria... Stage II Prosta... Stage II Renal ... Stage II Uterin... Stage IIA Cervi... Stage IIA Color... Stage IIA Ovari... Stage IIA Prost... Stage IIA1 Cerv... Stage IIA2 Cerv... Stage IIB Cervi... Stage IIB Color... Stage IIB Ovari... Stage IIB Prost... Stage IIC Color... Stage IIC Prost... Stage III Bladd... Stage III Cervi... Stage III Color... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Blad... Stage IIIA Cerv... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIA Uter... Stage IIIA1 Ova... Stage IIIA2 Ova... Stage IIIB Blad... Stage IIIB Cerv... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIB Uter... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IIIC Uter... Stage IIIC1 Ute... Stage IIIC2 Ute... Stage IV Bladde... Stage IV Cervic... Stage IV Colore... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Bladd... Stage IVA Cervi... Stage IVA Color... Stage IVA Ovari... Stage IVA Prost... Stage IVA Uteri... Stage IVB Bladd... Stage IVB Cervi... Stage IVB Color... Stage IVB Ovari... Stage IVB Prost... Stage IVB Uteri... Stage IVC Color...	Patient Monitor... Questionnaire A...	18 Years -	City of Hope Medical Center
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer	NCT04734730	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib	18 Years -	City of Hope Medical Center
Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study	NCT04585932	Biochemically R... Metastatic Pros... Oligometastatic... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Apalutamide Degarelix Leuprolide Acet... Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	M.D. Anderson Cancer Center
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial	NCT05168618	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Atezolizumab Cabozantinib S-...	18 Years -	University of Utah
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer	NCT04734730	Castration-Sens... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Bicalutamide Degarelix Goserelin Aceta... Leuprolide Acet... Prednisone Questionnaire A... Talazoparib	18 Years -	City of Hope Medical Center
68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer	NCT04716725	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	68Ga-PSMA-11 Positron Emissi...	18 Years -	University of California, San Francisco
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer	NCT04067960	Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Anatomic Stage ... Biliary Tract C... Clinical Stage ... Clinical Stage ... Malignant Brain... Malignant Genit... Malignant Solid... Pancreatobiliar... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Prognostic Stag... Stage III Color... Stage III Ovari... Stage III Pancr... Stage III Prost... Stage IIIA Colo... Stage IIIA Ovar... Stage IIIA Pros... Stage IIIB Colo... Stage IIIB Ovar... Stage IIIB Pros... Stage IIIC Colo... Stage IIIC Ovar... Stage IIIC Pros... Stage IV Colore... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IVA Color... Stage IVA Ovari... Stage IVA Pancr... Stage IVA Prost... Stage IVB Color... Stage IVB Ovari... Stage IVB Pancr... Stage IVB Prost... Stage IVC Color...	Biospecimen Col... Genetic Testing Quality-of-Life... Questionnaire A...	-	Mayo Clinic
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer	NCT04134260	Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Apalutamide Hormone Therapy Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	NRG Oncology
68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer	NCT04050215	Biochemically R... Metastatic Pros... Prostate Adenoc... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Computed Tomogr... Gallium Ga 68-l... Positron Emissi... Questionnaire A...	18 Years -	Jonsson Comprehensive Cancer Center
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03709550	Castration Leve... Castration-Resi... Metastatic Pros... Prostate Carcin... PSA Level Great... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Decitabine Enzalutamide	18 Years -	Roswell Park Cancer Institute
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer	NCT03678025	Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin	18 Years -	SWOG Cancer Research Network
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy	NCT04915508	Prostate Adenoc... Stage IIIB Pros... Stage IIIC Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Hormone Therapy Stereotactic Bo...	18 Years -	Jonsson Comprehensive Cancer Center
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer	NCT03751436	Castration Leve... Castration-Resi... Metastatic Pros... Metastatic Pros... Prostate Carcin... PSA Progression Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Enzalutamide Venetoclax	18 Years -	Roswell Park Cancer Institute
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial	NCT04693377	Castration-Resi... Metastatic Colo... Metastatic Mali... Metastatic Mali... Metastatic Mela... Metastatic Pros... Metastatic Rena... Metastatic Sarc... Metastatic Thyr... Metastatic Urot... Stage IV Colore... Stage IV Prosta... Stage IV Renal ... Stage IVA Color... Stage IVA Prost... Stage IVB Color... Stage IVB Prost... Stage IVC Color...	Cryosurgery Quality-of-Life... Stereotactic Bo...	18 Years -	M.D. Anderson Cancer Center
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer	NCT03999515	Castration-Resi... Double-Negative... Metastatic Pros... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Ace... Enzalutamide Erdafitinib	18 Years -	University of Washington
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancer	NCT04037254	Prostate Adenoc... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... Stage IVA Prost...	Gonadotrophin R... Intensity-Modul... Niraparib	18 Years -	NRG Oncology
Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer	NCT03204812	Castration-Resi... Metastatic Mali... Prostate Adenoc... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Durvalumab Tremelimumab	18 Years -	M.D. Anderson Cancer Center
Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy	NCT05398302	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Image Guided Bi...	-	Jonsson Comprehensive Cancer Center
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05113537	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Metastatic Cast... Metastatic Cast...	Abemaciclib Lutetium Lu 177...	18 Years -	University of California, San Francisco
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer	NCT05113537	Castration-Resi... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost... Metastatic Cast... Metastatic Cast...	Abemaciclib Lutetium Lu 177...	18 Years -	University of California, San Francisco
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer	NCT03678025	Castration Leve... Metastatic Pros... Stage IV Prosta... Stage IVA Prost... Stage IVB Prost...	Abiraterone Bicalutamide Degarelix Docetaxel Flutamide Goserelin Aceta... Histrelin Aceta... Leuprolide Acet... Nilutamide Orchiectomy Prednisone Quality-of-Life... Radiation Thera... Radical Prostat... Triptorelin	18 Years -	SWOG Cancer Research Network

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: